SARS-CoV-2 infection in a highly experienced person living with HIV

AIDS. 2020 Jul 1;34(8):1257-1258. doi: 10.1097/QAD.0000000000002572.

Authors

Affiliations

¹ Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Malattie Infettive.
² Section of Infectious Diseases, Department of Safety and Bioethics, Catholic University of the Sacred Heart.
³ Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Medicina Generale, Rome, Italy.

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Anti-Bacterial Agents / administration & dosage
Anti-HIV Agents / administration & dosage
Antibodies, Monoclonal, Humanized / administration & dosage
Betacoronavirus / isolation & purification*
COVID-19
Coronavirus Infections / diagnosis*
Coronavirus Infections / pathology
Coronavirus Infections / therapy
Drug Therapy, Combination / methods
HIV Infections / complications*
Humans
Hydroxychloroquine / administration & dosage
Immunologic Factors / administration & dosage
Male
Oxygen Inhalation Therapy
Pandemics
Pneumonia, Viral / diagnosis*
Pneumonia, Viral / pathology
Pneumonia, Viral / therapy
SARS-CoV-2
Treatment Outcome

Substances

Anti-Bacterial Agents
Anti-HIV Agents
Antibodies, Monoclonal, Humanized
Immunologic Factors
Hydroxychloroquine
sarilumab